|
|
||||||||

*
Center for Cancer Research and Department of Biology,
Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139
Very few cultured CD8+ T cell clones can normally be
obtained from a single mouse and maintained in long-term culture. To
improve the yield, we immunized p53 mutant mice with peptides of Sendai
virus (FAPGNYPAL) and influenza virus (ASNENMETM) origin.
Substantially more clones could be derived from
p53-/- mice than from similarly treated wild-type
mice (p53+/+); an intermediate yield was obtained
from heterozygous mice (p53+/-). CTL lines or
clones from p53-/- mice exhibited greater proliferative
activity and resistance to
-irradiation than those from
p53+/+ mice, and were cytolytically
potent.
This article has been cited by other articles:
![]() |
X. Zhou, D. Y. Jun, A. M. Thomas, X. Huang, L.-Q. Huang, J. Mautner, W. Mo, P. F. Robbins, D. M. Pardoll, and E. M. Jaffee Diverse CD8+ T-Cell Responses to Renal Cell Carcinoma Antigens in Patients Treated with an Autologous Granulocyte-Macrophage Colony-Stimulating Factor Gene-Transduced Renal Tumor Cell Vaccine Cancer Res., February 1, 2005; 65(3): 1079 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Grayson, J. G. Lanier, J. D. Altman, and R. Ahmed The Role of p53 in Regulating Antiviral T Cell Responses J. Immunol., August 1, 2001; 167(3): 1333 - 1337. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |